Skip to content
Adial Pharmaceuticals
-
Adial Pharmaceuticals acquires Azora Therapeutics in US$64M IBD pipeline pivot
The deal combines acquisition with a concurrent private placement of up to US$64 million in gross proceeds before expenses, strengthening development funding.